title: Rheumatology in India--quo vadis?
abstract: Rheumatology has been a neglected subspecialty in India. A staggering patient load, a severely inadequate number of trained rheumatology specialists, therapeutic nihilism and limited advocacy are some of the critical challenges that confront rheumatology care, and possibly explain the high rates of reliance on complementary and alternative medicines in India. Disease spectrum and treatment patterns are not remarkably different from those in other countries, but biologic agents have limited use and are administered for short periods only. Consequently, outcomes in India do not yet match those reported in developed countries. Furthermore, the high prevalence of infectious diseases continues to be a major contributor to mortality in patients with rheumatic disorders such as systemic lupus erythematosus. Several tropical diseases with rheumatic manifestations are relevant in India, including chikungunya, brucellosis, leptospirosis, dengue and melioidosis. To address the many problems with rheumatology care in India, curricular reforms, capacity building, patient education and political support are sorely needed.
authors.affiliation: Indraprastha Apollo Hospitals, Sarita Vihar, New Delhi 110076, India.
authors.forename: Rohini
authors.initials: R
authors.lastname: Handa
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use; D017281:Cost of Illness; D006801:Humans; D007194:India / Q000453:epidemiology; D012216:Rheumatic Diseases / Q000191:economics / Q000453:epidemiology / Q000628:therapy; D012219:Rheumatology / Q000193:education / Q000458:organization & administration* / Q000592:standards / Q000639:trends
chemical_list: D018501:Antirheumatic Agents